Subthreshold micropulse laser adjuvant to bevacizumab versus bevacizumab monotherapy in treating diabetic macular edema: one- year- follow-up
Purpose: To compare the therapeutic impact of combining intravitreal injections of bevacizumab (IVB) with micropulse laser (MPL) in central diffuse diabetic macular edema (DME) versus IVB monotherapy during 12 months follow-up. Methods: We conducted a retrospective comparative study of 98 treatment-...
Main Authors: | Leila El Matri, Ahmed Chebil, Khaled El Matri, Yousra Falfoul, Zouheir Chebbi |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-09-01
|
Series: | Therapeutic Advances in Ophthalmology |
Online Access: | https://doi.org/10.1177/25158414211040887 |
Similar Items
-
Commentary: Subthreshold micropulse yellow laser in diabetic macular edema
by: Mayank Bansal
Published: (2020-01-01) -
Effects of subthreshold diode micropulse laser photocoagulation on treating patients with refractory diabetic macular edema
by: Mohammadreza Akhlaghi, et al.
Published: (2019-06-01) -
Bevacizumab Injection in Patients with Age-Related Macular Degeneration Associated with Poor Initial Visual Acuity
by: Leila El Matri, et al.
Published: (2012-01-01) -
Diabetic papillopathy with macular edema treated with intravitreal bevacizumab
by: Ahmed S Al-Hinai
Published: (2012-01-01) -
Diabetic papillopathy with macular edema treated with intravitreal bevacizumab
by: Ahmed S Al-Hinai, et al.
Published: (2011-01-01)